- All sections
- C - Chemistrymetallurgy
- C07K - Peptides
- C07K 14/545 - IL-1
Patent holdings for IPC class C07K 14/545
Total number of patents in this class: 250
10-year publication summary
|
9
|
15
|
15
|
17
|
15
|
14
|
20
|
21
|
8
|
5
|
| 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 | 2026 |
Principal owners for this class
| Owner |
All patents
|
This class
|
|---|---|---|
| Centre National de La Recherche Scientifique | 11077 |
11 |
| Universiteit Gent | 1410 |
11 |
| Vib VZW | 910 |
11 |
| Centre hospitalier Regional universitaire de Montpellier | 32 |
10 |
| Modernatx, Inc. | 1282 |
9 |
| Abbvie Inc. | 1799 |
7 |
| Rutgers, The State University of New Jersey | 1985 |
6 |
| Universite de Montpellier | 1043 |
5 |
| Orionis Biosciences Inc. | 112 |
5 |
| Amunix Pharmaceuticals, Inc. | 89 |
5 |
| Adda Biotech Inc. | 6 |
4 |
| Alkermes, Inc. | 136 |
4 |
| Baylor College of Medicine | 1010 |
4 |
| Eleven Biotherapeutics, Inc. | 18 |
4 |
| King's College London | 572 |
4 |
| Northeastern University | 1300 |
4 |
| Washington University | 1757 |
4 |
| Swedish Orphan Biovitrum AB (publ) | 162 |
4 |
| Novartis AG | 10175 |
3 |
| Wisconsin Alumni Research Foundation | 3903 |
3 |
| Other owners | 132 |